-
TROPION-Lung07 Phase 3 Trial Initiated to Evaluate Datopotamab Deruxtecan in Combination with Pembrolizumab in Patients with Previously Untreated Metastatic Non-Small Cell Lung Cancer
30 Jan 2023 13:19 GMT
… squamous non-small cell lung cancer remains a challenge … cell lung cancer, across PD-L1 segments and tumor histologies.”
… Small Cell Lung Cancer Without Actionable Genomic Alterations
Lung cancer is … is expressed across all lung cancer subtypes with the …
-
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
27 Jan 2023 12:12 GMT
… non-small cell lung cancer following surgery and … Platform (ETOP).
About lung cancer
Lung cancer is the leading cause … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … of squamous cell histology that express PD-L1 …
-
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
27 Jan 2023 12:06 GMT
… non-small cell lung cancer following surgery and … Platform (ETOP).
About lung cancer
Lung cancer is the leading cause … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … of squamous cell histology that express PD-L1 …
-
LUNGevity Partners with ASTRO to Issue RFA for Lung Cancer Research Grant
25 Jan 2023 21:09 GMT
… the treatment of lung cancer, irrespective of stage and histology of the disease … improving outcomes for people with lung cancer. The foundation works tirelessly to … HELPLine for support, the International Lung Cancer Survivorship Conference, and an easy …
-
Drug Therapeutics & Regulation in the U.S.
31 Jan 2023 16:02 GMT
… with his 1878 dissertation on histological staining, it was the result … evidence linking cigarette smoking to lung cancer and emphysema inspired the development …
-
Daiichi Sankyo begins patient dosing in TROPION─Lung07 phase 3 trial to evaluate datopotamab deruxtecan in combo with pembrolizumab to treat patients with previously untreated metastatic NSCLC
31 Jan 2023 13:48 GMT
… squamous non-small cell lung cancer remains a challenge because … cell lung cancer, across PD-L1 segments and tumour histologies.”
TROPION … , Asia and Oceania.
Lung cancer is the second most common … is expressed across all lung cancer subtypes with the highest …
-
Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients Treated with Definitive Chemoradiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma
30 Jan 2023 11:05 GMT
… carcinoma (ESCC) is the major histological type.1 The latest epidemiological … the prognosis of patients with lung cancer, liver cancer, colorectal cancer, head … and IIIB) non-small cell lung cancer treated with combined modality therapy …
-
Cell-Based Drug Delivery Systems with Innate Homing Capability as a Novel Nanocarrier Platform
29 Jan 2023 00:13 GMT
… , et al. Cerebral neutrophil recruitment, histology, and outcome in acute ischemic … , Zeng X, et al. Efficient lung cancer-targeted drug delivery via a … the systemic treatment of metastatic lung cancer. Drug Deliv. 2017;24(1 …
-
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy in First-Line Advanced or Unresectable Biliary Tract Cancer in KEYNOTE-966 Trial
25 Jan 2023 11:55 GMT
… complete resection.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with pemetrexed … metastatic nonsquamous non-small cell lung cancer (NSCLC), with no EGFR or … with tumors of squamous cell histology that express PD-L1 (CPS …
-
Merck Announces KEYNOTE-991 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Enzalutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer to Stop for Futility
25 Jan 2023 11:55 GMT
… complete resection.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with pemetrexed … metastatic nonsquamous non-small cell lung cancer (NSCLC), with no EGFR or … with tumors of squamous cell histology that express PD-L1 (CPS …
About
© 1995-2023